Keywords: lisinopril, products, get, patent, reprieve, usa, merck

Lisinopril products get patent reprieve in USA

Article | 27 November 2001

Print This

Merck & Co and AstraZeneca have said that the US Food and DrugAdministration has granted the firms an additional six months ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in